Previous close | 4.4900 |
Open | 4.5100 |
Bid | 4.5100 x 100 |
Ask | 4.5400 x 600 |
Day's range | 4.4850 - 4.6450 |
52-week range | 3.8700 - 8.0500 |
Volume | |
Avg. volume | 1,457,959 |
Market cap | 1.326B |
Beta (5Y monthly) | 0.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
VANCOUVER, British Columbia, March 19, 2024--AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Bloom Burton Healthcare Conference on Tuesday, April 16, 2024, at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time).
VANCOUVER, British Columbia, March 11, 2024--AbCellera (Nasdaq: ABCL) and Biogen Inc. (Nasdaq: BIIB) have entered into a strategic collaboration to discover antibodies for a novel target that enables the delivery of biotherapeutics to the brain for indications in neuroscience.
VANCOUVER, British Columbia, March 05, 2024--AbCellera (Nasdaq: ABCL) today announced that its scientists will present four posters with data from its T-cell engager programs and platform at the American Association for Cancer Research (AACR) Annual Meeting 2024, to be held April 5 to 10 at the San Diego Convention Center.